hJAA-F11 ADC (For-Robin)

N/A

Report date: 2025/03/20 15:09:13

Base Information

Drug NamehJAA-F11 ADC (For-Robin)

Drug Alias Nameanti-Thomsen-Friedenreich glycoantigen monoclonal antibody-drug conjugate (For-Robin)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugate

Mechanisms of ActionMetastasis inhibitorsImmunomodulators

TargetsUpdating

Therapy Area/IndicationsLung NeoplasmsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesFor-Robin Inc

China Registration ClassN/A

Develop Information

Active CompaniesFor-Robin Inc

Inactive CompaniesN/A

Active IndicationsLung NeoplasmsBreast Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A